Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Livongo Health Inc (LVGO)

Livongo Health Inc (LVGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,770,458
  • Shares Outstanding, K 101,585
  • Annual Sales, $ 170,200 K
  • Annual Income, $ -55,270 K
  • 60-Month Beta 1.77
  • Price/Sales 85.29
  • Price/Cash Flow N/A
  • Price/Book 24.18
Trade LVGO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.03
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate -0.09
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
134.71 +7.94%
on 10/26/20
151.05 -3.74%
on 10/13/20
+7.98 (+5.81%)
since 09/28/20
3-Month
111.35 +30.58%
on 08/10/20
151.05 -3.74%
on 10/13/20
+34.13 (+30.67%)
since 07/28/20
52-Week
18.76 +675.05%
on 03/16/20
151.05 -3.74%
on 10/13/20
+122.73 (+541.38%)
since 10/28/19

Most Recent Stories

More News
Livongo Health (LVGO) Beats Q3 Earnings and Revenue Estimates

Livongo Health (LVGO) delivered earnings and revenue surprises of 300.00% and 11.02%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

LVGO : 145.40 (+1.76%)
Livongo Health: 3Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Livongo Health Inc. (LVGO) on Wednesday reported a loss of $25.5 million in its third quarter.

LVGO : 145.40 (+1.76%)
Livongo Reports Third Quarter 2020 Financial Results

-- Third quarter total revenue of $106.1 million, up 126% year-over-year

LVGO : 145.40 (+1.76%)
TDOC : 226.94 (+1.74%)
Medical Products Q3 Earnings on Oct 28: BSX, CERN & More

In Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions in many states and regions. However, international sales might have been dampened.

CERN : 70.64 (-2.89%)
BSX : 34.07 (-5.49%)
PEN : 232.72 (-2.56%)
LVGO : 145.40 (+1.76%)
Livongo Health (LVGO) to Post Q3 Earnings: What's in Store?

Livongo Health's (LVGO) third-quarter results are likely to reflect growth in core Livongo for Diabetes solution.

PACB : 13.97 (-4.58%)
GWPH : 88.82 (-2.13%)
ZBH : 133.37 (-3.77%)
LVGO : 145.40 (+1.76%)
Teladoc's (TDOC) Telemedicine Service to Improve Mental Health

Teladoc Health (TDOC) rolls out a new telemedicine solution to address mental health issues of Canadian employees.

HUM : 413.25 (-4.37%)
MGLN : 73.12 (-2.27%)
TDOC : 226.94 (+1.74%)
LVGO : 145.40 (+1.76%)
Livongo Health (LVGO) Stock Sinks As Market Gains: What You Should Know

Livongo Health (LVGO) closed at $142.75 in the latest trading session, marking a -0.39% move from the prior day.

LVGO : 145.40 (+1.76%)
Livongo Signs Strategic Partnership with GuideWell Accelerating Care Delivery to Vulnerable Populations

, /PRNewswire/ -- GuideWell Mutual Holding Corporation (), the parent to a family of forward-thinking companies focused on transforming health care, announced a strategic agreement today with Livongo...

LVGO : 145.40 (+1.76%)
Telehealth Stocks Gain New Wings Following the Push for Expanded Access

, /PRNewswire/ -- The era of telehealth is upon us. As patients try to avoid hospital rooms right now, a growing number of people have turned to telehealth from the comfort of their home to limit contact...

TDOC : 226.94 (+1.74%)
CVS : 56.57 (-2.72%)
LVGO : 145.40 (+1.76%)
MYCO.CN : 0.200 (-6.98%)
Livongo Health (LVGO) Stock Moves -0.43%: What You Should Know

Livongo Health (LVGO) closed at $147.44 in the latest trading session, marking a -0.43% move from the prior day.

LVGO : 145.40 (+1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Livongo Health Inc. is a consumer digital health company. It offers Enter Livongo platform, which leverages data science and technology, for people with chronic conditions. The Company's Livongo platform offers solutions, such as Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes...

See More

Key Turning Points

2nd Resistance Point 151.87
1st Resistance Point 148.64
Last Price 145.40
1st Support Level 141.37
2nd Support Level 137.33

See More

52-Week High 151.05
Last Price 145.40
Fibonacci 61.8% 100.51
Fibonacci 50% 84.90
Fibonacci 38.2% 69.29
52-Week Low 18.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar